Prof. Dr. Stefanie J. Klug



Academic Career and Research Areas

Prof. Klug's research focus is the prevention of chronic diseases. Her research focuses on cancer epidemiology, secondary data analyses, epidemiological and statistical methods, health services research, molecular epidemiology and human papillomavirus (HPV) infections. Furthermore, international collaborations in the field of Global Cancer and Global Surgery characterize the chair.

Prof. Klug studied biology at the University of Regensburg and molecular biology at the University of Colorado at Boulder, USA, and received her PhD in 1997 at the Gene Center of the Ludwig-Maximilians-University Munich (LMU). She then studied public health and epidemiology at the LMU. After research stays at the International Agency for Research on Cancer (IARC) in Lyon, France, and at the Faculty of Health Sciences at Bielefeld University, she habilitated at the University Medical Center of Mainz University in 2008. In 2010, she was appointed to the professorship of Tumor Epidemiology at the University Cancer Center of the University Hospital of TU Dresden. In July 2016, she took over the newly established Chair of Epidemiology at TUM.


  • Award of the Stiftung Präventive Pädiatrie (2009)
  • Bavarian Public Health Lion (1999)

Eberl M., Fiengo Tanaka L., Kraywinkel K., Klug S.J. “Incidence of smoking-related second primary cancers after lung cancer in Germany: an analysis of nationwide cancer registry data”. Journal of Thoracic Oncology. 2022; 17(3): 388–98.


Stelzle D, Tanaka LF, Lee KK, Ibrahim Khalil A, Baussano I, Shah ASV, McAllister DA, Gottlieb SL, Klug SJ, Winkler AS, Bray F, Baggaley R, Clifford GM, Broutet N, Dalal S: “Estimates of the global burden of cervical cancer associated with HIV”. The Lancet Global Health. 2021; 9: e161-69.


Liang LA, Einzmann T, Franzen A, Schwarzer K, Schauberger G, Schriefer D, Radde K, Zeissig SR, Ikenberg H, Meijer CJ, Kirkpatrick CJ, Kölbl H, Blettner M, Klug SJ: “Cervical Cancer Screening: Comparison of conventional Pap smear test, liquid-based cytology and human papillomavirus testing as stand-alone or co-testing strategies”. Cancer Epidemiology Biomarkers and Prevention. 2021; 30(3): 474-484.


Radde K, Gottschalk A, Bussas U, Neumann A, Seifert U, Schülein S, Kaiser M, Blettner M, Klug SJ: “Invitation to cervical cancer screening does increase participation in Germany: results from the MARZY Study”. International Journal of Cancer. 2016; 139(5): 1018-1030.


Klug SJ, Ressing M, König J, Abba MC, Agorastos T, Brenna SMF, Ciotti M, Das BR, del Mistro A, Dybikowska A, Giuliano AR, Gudleviciene Z, Gyllensten U, Haws A, Helland A, Herrington CS, Hildesheim A, Humbey O, Jee SH, Kim JW, Madeleine MM, Menczer J, Ngan H, Nishikawa A, Niwa Y, Pegoraro R, Pillai MR, Ranzani GN, Rezza G, Rosenthal A, Roychoudhury S, Saranath D, Schmitt VM, Sengupta S, Settheetham-Ishida W, Shirasawa H, Snijders P, Stoler MH, Suárez-Rincon AE, Szarka K, Tachezy R, Ueda M, van der Zee A, von Kebel Doeberitz M, Wu M-T, Yamashita T, Zehbe I, Blettner M: “TP53 codon 72 polymorphism and cervical cancer: pooled analysis of individual data of 15 834 women from 49 studies”. Lancet Oncology. 2009; 10(8): 772-784.